Cathie Wood's ARK ETFs have reported their daily trades for Thursday, September 12th, 2024, with significant activity across several sectors. The largest dollar-value trade was the purchase of 45541 shares of Advanced Micro Devices Inc (NASDAQ:AMD) through the ARKK ETF, totaling approximately $6.8 million. This move shows a continued bullish stance on the semiconductor industry, following a similar purchase earlier in the week.
Another notable trade was the acquisition of 177544 shares of DraftKings Inc (NASDAQ:DKNG), also through the ARKK ETF, matching the dollar value of the AMD purchase at roughly $6.8 million. This investment reflects ARK's confidence in the online sports betting company, adding to its position from earlier trades in the week.
ARK's buying spree extended to Personalis Inc (NASDAQ:PSNL), with the purchase of 284451 shares through the ARKG ETF, amounting to over $1.6 million. This genetic sequencing company has been a recurring interest for ARK, as seen in previous days' trades.
In the biotech sphere, ARK's ARKG ETF bought 15182 shares of Absci Corp (NASDAQ:ABSI) and 11785 shares of Guardant Health Inc (NASDAQ:GH), with dollar values of approximately $55,000 and $293,000, respectively. These trades suggest a targeted investment in innovative healthcare solutions.
On the sales front, ARK made a decisive move by selling 927180 shares of Unity Software Inc (NYSE:U) across its ARKK and ARKW ETFs, totaling around $15.9 million. This divestment marks a significant shift, as Unity has been a part of ARK's portfolio across multiple funds.
Other sales included 56411 shares of Butterfly Network (LON:NETW) Inc (NYSE:BFLY) and 19518 shares of Robinhood Markets Inc (NASDAQ:HOOD), with ARK seemingly reducing exposure to these companies with sales totaling approximately $109,000 and $403,000, respectively.
Smaller trades involved Blade Air Mobility Inc (NASDAQ:BLDE), 908 Devices Inc. (NASDAQ:MASS), Mynaric AG (NASDAQ:MYNA), and several others, indicating ARK's strategy of adjusting positions in emerging technology and health sectors.
Investors following ARK's ETFs might note the trends in the fund's buying patterns, with a clear focus on tech and healthcare stocks that align with ARK's investment philosophy centered around disruptive innovation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.